Apexus, the 340B prime vendor, asked a federal appeals court to affirm a lower court’s dismissal of claims that it [...] …
Category: Regulatory
Jazz Pharmaceuticals owes refunds to 340B providers, according to a notice posted on the Health Resources and Services Administration’s Office [...] …
Hospital groups will meet with federal executive branch officials to discuss coming changes to the 340B program’s administrative dispute resolution [...] …
GlaxoSmithKline owes refunds to 340B providers, according to a notice posted on the Health Resources and Services Administration’s Office of [...] …
A recent ruling by a federal district judge in South Carolina potentially could expand 340B-eligible prescriptions, say some provider advisers. [...] …
Hospital advocates praised the recent Medicare final rule implementing a $9 billion lump sum payment to 340B hospitals but worried [...] …
A federal district judge in Illinois has dismissed a Chicago hospital’s apparently successful lawsuit challenging its termination from the 340B [...] …
A group of Senate Republicans recently urged federal regulators to withdraw a plan to change the definition of a drug’s [...] …
Medicare Part B will continue to pay hospitals for 340B drugs at the rate of average sales price (ASP) plus [...] …
Medicare issued a final rule today to implement a $9 billion lump sum payment to 340B hospitals and to cut [...] …